RBC Capital analyst Luca Issi maintained a Hold rating on Wave Life Sciences (WVE – Research Report) yesterday and set a price target of $15.00. The company’s shares closed yesterday at $15.89. Issi ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback